VARS2 V552V variant as prognostic marker in patients with early breast cancer
暂无分享,去创建一个
Sang Kyun Sohn | Ho Yong Park | Ji Young Park | Joon Ho Moon | Hye Jung Kim | Sang-Woo Lee | J. Park | H. Kim | Y. Chae | S. Sohn | Sang-Woo Lee | Soo Jung Lee | J. Jung | H. Park | Yee Soo Chae | Byung Woog Kang | Jong Gwang Kim | Jin Hyang Jung | J. Moon | B. Kang
[1] M. Horowitz,et al. MHC class I, II, and III microsatellite marker matching and survival in unrelated donor hematopoietic cell transplantation. , 2007, Tissue antigens.
[2] D. Kang,et al. Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. , 2008, Asian Pacific journal of cancer prevention : APJCP.
[3] L. Harris,et al. First-Line Herceptin® Monotherapy in Metastatic Breast Cancer , 2001, Oncology.
[4] W. Lafuse,et al. The mouse p52 subunit of the transcription/DNA repair factor TFIIH is located in the class III region of the H2 complex: cloning and sequence polymorphism , 1999, Immunogenetics.
[5] Paul Schimmel,et al. Global effects of mistranslation from an editing defect in mammalian cells. , 2006, Chemistry & biology.
[6] L. Oomen,et al. A susceptibility gene for alveolar lung tumors in the mouse maps between Hsp70.3 and G7 within the H2 complex , 2004, Immunogenetics.
[7] B. Ponder,et al. Common Single-Nucleotide Polymorphisms in DNA Double-Strand Break Repair Genes and Breast Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.
[8] W. Jin,et al. Genetic Polymorphisms in the DNA Repair Enzyme ERCC2 and Breast Tumour Risk in a Chinese Population , 2008, The Journal of international medical research.
[9] A. Hart,et al. Effects of the MHC on hormonal induction of mammary tumors and function of hypophyseal isografts in the mouse , 2005, Immunogenetics.
[10] J. Błasiak,et al. Polymorphisms of the DNA Mismatch Repair Gene HMSH2 in Breast Cancer Occurence and Progression , 2005, Breast Cancer Research and Treatment.
[11] X. Shu,et al. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[12] C. Ulrich,et al. Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[13] Robert W. Taylor,et al. Overexpression of human mitochondrial valyl tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying the pathogenic C25U mutation , 2008, Nucleic acids research.
[14] Chia-Hung Liu,et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization , 2006, Nucleic Acids Res..
[15] M. Snoek,et al. Genotype versus phenotype: conflicting results in mapping a lung tumor susceptibility locus to the G7c recombination interval in the mouse MHC class III region , 2001, Immunogenetics.
[16] L. Cardon,et al. Fine mapping of the MHC Class III region demonstrates association of AIF1 and rheumatoid arthritis. , 2008, Rheumatology.
[17] C. Teuscher,et al. Molecular analysis of the major MHC recombinational hot spot located within the G7c gene of the murine class III region that is involved in disease susceptibility. , 1998, Journal of immunology.
[18] P. Schimmel,et al. An editing-defective aminoacyl-tRNA synthetase is mutagenic in aging bacteria via the SOS response , 2007, Proceedings of the National Academy of Sciences.
[19] S. Ackerman,et al. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration , 2006, Nature.
[20] P. Hutter,et al. Two common forms of the human MLH1gene may be associated with functional differences , 2000, Journal of medical genetics.
[21] J. Jiricny,et al. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. , 2002, Gastroenterology.